Emerald Health Therapeutics has signed an agreement with Skye Bioscience.
Greg Fleury has joined the CBD company.
The appointment will be made following suspension of the company’s shares from the AQSE.
Home Two former Johnson & Johnson executives teamed up in 2020 to bring their experience in consumer medical products to the CBD industry and create products...
A new study has concluded that the State’s cannabis tax must be eliminated to move consumers away from illicit products.
The UK government has the opportunity plan for the creation of a long-term cannabis industry, the All Party Parliamentary Group (APPG) for CBD Products has stated.
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and...
Cannabis Wealth speaks to Cellular Goods about advertising and sales restrictions and its appearance on Amazon’s new UK CBD product pilot.
The US-based company operating primarily in Switzerland has plans to expand into the German market.
Five US companies have been issued warning letters.
In the first of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of lighting for improving cannabis yield.
The platform aims to be a premium destination for industry members to connect.
HempStreet and MGC Pharmaceuticals have teamed up to increase access to phytopharmaceutical medicines for patients.